Furthermore, in patients undergoing adoptive transfer of TILs, tumor regression mediated by both CD4+ and CD8+ T cells is specifically directed against neoantigens, underscoring the critical role of neoantigen recognition in effective antitumor responses (219, 222–224). The gene discussed is CD8A; the disease is neoplasm.